Fecal occult blood testing for colorectal cancer: Can we afford to do this?

Gastroenterology Clinics of North America

Volumn 26, Issue 1, 1997, Pages 41-55

  Ahlquist, D A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER MORTALITY; CANCER PREVENTION; CANCER SCREENING; COLORECTAL CANCER; COST BENEFIT ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HEALTH CARE COST; HUMAN; OCCULT BLOOD; REVIEW;

EID: 0031058861     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8553(05)70282-X     Document Type: Article

References (73)

1. D.A. Ahlquist Occult gastrointestinal bleeding Yamada T. Textbook of Gastroenterology ed 2 1995 JB Lippincott Philadelphia 699 717
2. D.A. Ahlquist J.A. Gilbert Novel fecal markers for colorectal cancer screening: Future considerations Dig Dis 14 1996 132 144
3. D.A. Ahlquist D.B. McGill J.L. Fleming Patterns of occult bleeding in asymptomatic colorectal cancer Cancer 63 1989 1826 1830
4. D.A. Ahlquist D.B. McGill S. Schwartz HemoQuant, a new quantitative assay for fecal hemoglobin: Comparision with Hemoccult Ann Intern Med 101 1984 297 302
5. D.A. Ahlquist D.B. McGill S. Schwartz Fecal blood levels in health and disease: A study using HemoQuant N Engl J Med 312 1985 1422 1428
6. D.A. Ahlquist H.S. Wieand C.G. Moertel Accuracy of fecal occult blood screening for colorectal neoplasia: A prospective study using Hemoccult and HemoQuant tests JAMA 269 1993 1262 1267
7. O.E. Akwari K.A. Kelly Anterior resection for adenocarcinoma of the distal large bowel Am J Surg 139 1980 88 93
8. J.E. Allison R. Feldman I.S. Tekawa Hemoccult screening in detecting colorectal neoplasm: Sensitivity, specificity, and predictive value Ann Intern Med 112 1990 328 333
9. J.E. Allison I.S. Tekawa L.S. Ransom A comparison of fecal occult blood tests for colorectal cancer screening N Engl J Med 334 1996 155 159
10. K.M. Bang S. Tillett S.K. Noar Sensitivity of fecal Hemoccult testing and flexible sigmoidoscopy for colorectal cancer screening J Occup Med 28 1986 709 713
11. I. Bosa Uber okkulte magen blumtunge Dtsch Med Wochenschr 27 1901 315 318
12. M.L. Crowley L.D. Freeman M.D. Mottet Sensitivity of Guaiac-impregnated cards for the detection of colorectal neoplasia J Clin Gastroenterol 5 1983 127 130
13. R.Y. Demers L.E. Stawick P. Demers Relative sensitivity of the fecal occult blood test and flexible sigmoidoscopy in detecting polyps Prev Med 14 1985 55 62
14. J. Doran J.D. Hardcastle Bleeding patterns in colorectal cancer: The effect of aspirin and implications for faecal occult blood testing Br J Surg 69 1982 711
15. R. Dubrow L. Yannieli Fecal protein markers of colorectal cancer Am J Gastroenterol 87 1992 854 858
16. D.M. Eddy Screening for colorectal cancer Ann Intern Med 113 1990 373 384
17. D.M. Eddy Comparing benefits and harms: The balance sheet JAMA 263 1990 2493 2505
18. D.M. Eddy T.W. Nugent J.F. Eddy Screening for colorectal cancer in a high-risk population: Results of a mathematical model Gastroenterology 92 1987 682 692
19. L.P. Fielding R.K.S. Phillips R. Hittlinger Factors influencing mortality after curative resection for large bowel cancer in elderly patients Lancet 1 1989 595 597
20. J.W. Frank Occult blood screening for colorectal cancer: The yield and costs Am J Prev Med 1 1985 18 24
21. D.H. Greegor Occult blood testing for detection of asymptomatic colon cancer Cancer 28 1971 131 134
22. C.D.M. Griffith D.J. Turner J.H. Saunders False-negative results of Hemoccult test in colorectal screening BMJ 283 1981 472 473
23. A. Habr-Gama J.D. Waye Complications and hazards of gastrointestinal endoscopy 13 1989 193 199
24. J.D. Hardcastle J. Chamberlain J. Sheffield Randomized, controlled trial of faecal occult blood screening for colorectal cancer Lancet 1 1989 1160 1164
25. F.L. Iber A. Lira D.M. Kruss Apnea and cardiopulmonary arrest during and after endoscopy J Clin Gastroenterol 14 1992 109 113
26. Y. Iida Y. Munemato S. Miura Clinicopathologic studies of immunologic fecal occult blood test for colorectal cancer J Gastroenterol 30 1995 192 200
27. D.G. Illingworth Influence of diet on occult blood tests Gut 6 1965 595 599
28. R.M. Jaffe B. Kasten D.S. Young False-negative stool ocult blood tests caused by ingestion of ascorbic acid (vitamin C) Ann Intern Med 83 1975 824 826
29. H. Jahn O.K. Joergensen O. Kronborg Can Hemoccult II replace colonoscopy after radical surgery for colorectal cancer or after polypectomy? Dis Colon Rectum 35 1992 253 256
30. J. Kewenter S. Bjork E. Haglind Screening and rescreening for colorectal cancer, a controlled trial of fecal occult blood testing in 27,700 subjects Cancer 62 1988 645 651
31. O. Kronborg C. Fenger J. Olsen Repeated screening for colorectal cancer with fecal occult blood test Scand J Gastroenterol 24 1989 599 606
32. C.A. Lang D.F. Ransohoff Fecal occult blood screening for colorectal cancer: Is mortality reduced by chance selection for screening colonoscopy? JAMA 271 1994 1011 1013
33. D. Lazovich N.S. Weiss N.G. Stevens A case-control study to evaluate the effectiveness of screening for fecal occult blood J Med Screen 2 1995 84 89
34. J.M. Lee Screening and informed consent N Engl J Med 328 1993 438 439
35. A.A.M. Lewis G.A. Khoury Resection for colorectal cancer in the very old: Are the risks too high? BMJ 296 1988 459 561
36. D.A. Lieberman Cost-effectiveness model for colon cancer screening Gastroenterology 109 1995 1781 1790
37. S. Ma R.K.H. Wong J.W. Kikendall Detection of p53 gene mutations in exfoliated human colonic epithelial cells isolated from stools of subjects undergoing colonoscopy Gastroenterology 104 1993 A423
38. F.A. Macrae St John D.J.B. Relationship between patterns of bleeding and Hemoccult sensitivity in patients with colorectal cancers or adenomas Gastroenterology 92 1982 891 898
39. F.A. Macrae St John D.J.B. Caligiore P. Optimal dietary conditions for Hemoccult testing Gastroenterology 82 1982 899 905
40. J.S. Mandel J.H. Bond T.R. Church Reducing mortality from colorectal cancer by screening for fecal occult blood N Engl J Med 328 1993 1365 1371
41. G.R. Morrow J. Way A.C. Hoagland Patient compliance with self-directed Hemoccult testing Prev Med 11 1982 512 517
42. A.D. Muller A. Sonnenberg Protection by endoscopy against death from colorectal cancer: A case-control study among veterans Arch Intern Med 155 1995 1741 1748
43. A.D. Muller A. Sonnenberg Prevention of colorectal cancer by flexible endoscopy and polypectomy—a case control study of 32,702 veterans Ann Intern Med 123 1995 904 910
44. T. Nakagama H. Yasuoko T. Kishino ELISA for occult fecal albumin Lancet 1 1992 1368 1369
45. P.A. Newcomb R.G. Norfleet B.E. Storer Screening sigmoidoscopy and colorectal cancer mortality J Natl Cancer Inst 84 1992 1572 1575
46. S. Nichols E. Koch R.C. Lallermand Randomized trial of compliance with screening for colorectal cancer BMJ (Clin Res) 293 1986 107 112
47. J.D. Ostrow C.A. Mulvaeny J.R. Hansell Sensitivity and reproducibility of chemical tests for fecal occult blood with an emphasis on false-positive reactions Am J Dig Dis 18 1973 930 940
48. D.F. Ransohoff C.A. Lang Small adenomas detected during fecal occult blood test screening for colorectal cancer: The impact of serendipity JAMA 263 1990 76 78
49. A. Ribet J. Frexinos J. Escourrou Occult blood tests and colorectal tumors Lancet 1 1980 417 421
50. M.H.E. Robinson O. Kronborg C.B. Williams Faecal occult blood testing and colonoscopy in the surveillance of subjects at high risk of colorectal neoplasia Br J Surg 82 1995 318 320
51. A.G. Roseth M.K. Fagerhol E. Aadland Assessment of the neutrophil dominating protein calprotectin in feces: A methodologic study Scand J Gastroenterol 27 1992 793 798
52. A.G. Roseth J. Kristinsson K. Nygaard Faecal lactoferrin: A novel marker of colorectal cancer in rats, a longitudinal in vivo study Gastroenterology 108 1995 A530
53. P. Rozen Screening for colorectal neoplasia in the Tel Aviv area: Cumulative data 1979-89 and initial conclusions Isr J Med Sci 28 1992 8 20
54. S.M. Scheitel D.A. Ahlquist P.C. Wollan Colorectal cancer screening: A case control community study J Gen Intern Med 10 1995 5103
55. J.J. Schentag False positive 'Hemoccult' reaction with cimetidine N Engl J Med 303 1980 110 112
56. S. Schwartz J. Dahl M. Ellefson The HemoQuant test: A specific and quantitative determination of heme (hemoglobin) in feces and other materials Clin Chem 29 1983 2061 2067
57. J.V. Selby G.D. Friedman C.P.J. Quesenberry Effect of fecal occult blood testing on mortality from colorectal cancer: A case control study Ann Intern Med 118 1993 1 6
58. J.V. Selby G.D. Friedman C.P. Quesenberry A case-control study of screening sigmoidoscopy and mortality from colorectal cancer N Engl J Med 326 1992 653 657
59. T. Shimano H. Okuda T. Monden Usefulness of carcinoembryonic antigen measurement in feces of patients with colorectal cancer Dis Colon Rectum 30 1987 607 610
60. D. Sidransky T. Tokino S.R. Hamilton Identification of ras oncogen mutations in the stool of patients with curable colorectal tumors Science 256 1992 102 105
61. J.B. Simon Occult blood screening for colorectal carcinoma: A critical review Gastroenterology 88 1985 820 837
62. M.J. Solomon R.S. McLeod Periodic health examination—1994 update: 2. Screening strategies for colorectal cancer Can Med Assoc J 150 1994 1961 1970
63. J.R. Stroehlein V.G. Fairbanks V.L. Go Hemoccult stool tests: False-negative results due to storage of specimens Mayo Clin Proc 51 1976 548 552
64. R.S. Stubbs D.M. Nadkarni H.A. Monsey Fecal carcinoembryonic antigen (CEA) in patients with large bowel cancer Eur J Surg Oncol 13 1987 433
65. M. Tobi F.C. Luo A. Roani Detection of K- ras mutation in colonic effluent samples from patients without evidence of colorectal cancer J Natl Cancer Inst 86 1994 1007 1010
66. US Preventive Services Task Force Guide to Clinical Preventive Services ed 2 1996 Williams & Wilkins Baltimore
67. US Preventive Services Task Force Recommendations for fecal occult blood screening JAMA 261 1989 586
68. J. VanDeen Tincture gaujaci, und ein ozontrague, als reagens auf sehr geringe blutmengen, namenthlich in medico-forensischen falen Arch Holland Beitr Natura Heilk 3 1864 228 232
69. J.L. Wagner S. Tunis M. Brown The cost-effectiveness of colorectal cancer screening in average risk adults G.P. Young P. Rozen Levin B. Prevention and Early Detection of Colorectal Cancer 1996 WB Saunders London 321 356
70. J. Wahrendorf B.P. Robra H. Wiebelt Effectiveness of colorectal cancer screening: Results from a population-based case control evaluation in Saarland, Germany Eur J Cancer Prev 2 1993 221 227
71. J.D. Waye B.S. Lewis S. Yessayan Colonoscopy: A prospective report of complications Lancet 15 1992 347 351
72. C.B. Williams F.A. Macrae C.I. Bartram A prospective study of diagnostic methods in adenoma follow-up Endoscopy 14 1982 74 78
73. S.J. Winawer B.J. Flehinger D. Schottenfeld Screening for colorectal cancer with fecal blood testing and sigmoidoscopy J Natl Cancer Inst 85 1993 1311